Patients with a failed transplant face a higher mortality risk compared to those with a working graft, particularly in the ...

Since the first Breast Cancer Awareness Month initiatives kicked off 40 years ago, improvements have been made in treating ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Cancer patients are more likely to survive if they live in a state that expanded its Medicaid program under the Affordable Care Act, new research shows. Patients were more likely to have higher ...

Since the first Breast Cancer Awareness Month initiatives kicked off 40 years ago, major improvements have been made in treating the disease. While the rates of women diagnosed with breast cancer have ...

Loqtorzi significantly improved progression-free and overall survival in HER2-expressing advanced urothelial carcinoma compared to chemotherapy. The study demonstrated a higher overall response rate ...

Sacituzumab tirumotecan significantly reduced progression or death risk by 51% compared to chemotherapy in EGFR-mutated non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors. The ...

Oct 19 (Reuters) - AstraZeneca (AZN.L) and Daiichi Sankyo's (4568.T) new breast cancer drug helped significantly extend ...

The study results reflect the effect of surgery with lymph node dissection alone in patients with high-grade invasive bladder cancer.

WILSON, N.C. (WTVD) -- You wouldn't know it if she didn't tell you, but Saptosa Foster has been a silent warrior over the past year. She's been battling a disease that didn't run in her family.